Milestone Analyses of Immune Checkpoint Inhibitors, Targeted Therapy, and Conventional Therapy in Metastatic Non–Small Cell Lung Cancer Trials: A Meta-analysis

IMPORTANCE: Novel intermediate end points may be useful to detect signals of early activity and prioritize new therapies to treat patients with advanced malignant neoplasms, including metastatic non–small cell lung cancer (mNSCLC). OBJECTIVE: To explore milestone rate, a proposed intermediate end po...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:JAMA Oncol
Hauptverfasser: Blumenthal, Gideon M., Zhang, Lijun, Zhang, Hui, Kazandjian, Dickran, Khozin, Sean, Tang, Shenghui, Goldberg, Kirsten, Sridhara, Rajeshwari, Keegan, Patricia, Pazdur, Richard
Format: Artigo
Sprache:Inglês
Veröffentlicht: American Medical Association 2017
Schlagworte:
Original Investigation
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5824222/
https://ncbi.nlm.nih.gov/pubmed/28617920
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaoncol.2017.1029
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge